Activity of oral agents against pediatric isolates of Streptococcus pneumoniae

被引：3
|
作者：
Black, J
Moland, ES
Chartrand, SA
Thomson, KS
机构：
[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Anti Infect & Biotechnol, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Pediat Infect Dis, Omaha, NE 68178 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2001年 / 39卷 / 03期
关键词：
D O I：
10.1016/S0732-8893(01)00209-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
An in vitro study of the activity of 10 oral agents against 153 pediatric isolates of Streptococcus pneumoniae identified moxifloxacin and levofloxacin as the most active agents regardless of penicillin or macrolide susceptibility. Moxifloxacin inhibited all strains at 0.25 mug/ml and was 8- to 16-fold more potent than levofloxacin. (C) 2001 Elsevier Science inc. All rights reserved.
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [41] Activity of Ertapenem and 19 other antimicrobial agents against beta-lactam-resistant Streptococcus pneumoniae and Haemophilus influenzae respiratory tract isolates
    Gómez-Garcés, JL
    Alós, JI
    Alhambra, A
    Hernáiz, C
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2005, 23 (02): : 67 - 70
  • [42] SURVEY OF ISOLATES OF STREPTOCOCCUS PNEUMONIAE
    WOOD, NG
    NEW ZEALAND MEDICAL JOURNAL, 1976, 83 (559) : 154 - 155
  • [43] The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Clyde Thornsberry
    P. Ogilvie
    H. P. Holley
    M. L. Hickey
    M. E. Jones
    I. A. Critchley
    D. F. Sahm
    Drugs, 1999, 58 : 346 - 348
  • [44] The activity of fluoroquinolones and other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Thornsberry, C
    Ogilvie, P
    Holley, HP
    Hickey, ML
    Jones, ME
    Critchley, IA
    Sahm, DF
    DRUGS, 1999, 58 (Suppl 2) : 346 - 348
  • [45] INVITRO ACTIVITY OF 10 ANTIMICROBIAL AGENTS AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE
    NEAL, TJ
    ODONOGHUE, MAT
    RIDGWAY, EJ
    ALLEN, KD
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 (01) : 39 - 46
  • [46] In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida
    Mortensen, JE
    Giger, O
    Rodgers, GL
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 30 (02) : 99 - 102
  • [47] Activities of faropenem, an oral β-lactam, against recent US isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Critchley, IA
    Karlowsky, JA
    Draghi, DC
    Jones, ME
    Thornsberry, C
    Murfitt, K
    Sahm, DF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 550 - 555
  • [48] In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities
    Ioannidou, S
    Tassios, PT
    Zachariadou, L
    Salem, Z
    Kanelopoulou, M
    Kanavaki, S
    Chronopoulou, G
    Petropoulou, N
    Foustoukou, M
    Pangalis, A
    Trikka-Graphakos, E
    Papafraggas, E
    Vatopoulos, AC
    CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 704 - 707
  • [49] In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
    Banche, G.
    Roana, J.
    Allizond, V.
    Andreotti, S.
    Malabaila, A.
    Vigni, N. Li
    Mandras, N.
    Scalas, D.
    Tullio, V.
    Carlone, N. A.
    Savoia, D.
    Gaido, E.
    Barbui, A.
    Cuffini, A. M.
    LETTERS IN APPLIED MICROBIOLOGY, 2008, 47 (04) : 309 - 314
  • [50] In vivo activity of levofloxacin against isolates of Streptococcus pneumoniae possessing parC and parC/gyrA mutations.
    Ernst, EJ
    Klepser, ME
    Doern, GV
    PHARMACOTHERAPY, 2003, 23 (03): : 403 - 403
12345